Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $30 million versus the consensus estimate of $28.63 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.